HUE058848T2 - FGF-18 vegyületre vonatkozó válaszkészség elõrejelzésére szolgáló gyulladásos biomarkerek - Google Patents

FGF-18 vegyületre vonatkozó válaszkészség elõrejelzésére szolgáló gyulladásos biomarkerek

Info

Publication number
HUE058848T2
HUE058848T2 HUE18782012A HUE18782012A HUE058848T2 HU E058848 T2 HUE058848 T2 HU E058848T2 HU E18782012 A HUE18782012 A HU E18782012A HU E18782012 A HUE18782012 A HU E18782012A HU E058848 T2 HUE058848 T2 HU E058848T2
Authority
HU
Hungary
Prior art keywords
fgf
compound
predicting responsiveness
inflammatory biomarkers
biomarkers
Prior art date
Application number
HUE18782012A
Other languages
English (en)
Hungarian (hu)
Inventor
Christoph H Ladel
Hans Guehring
Anne-Christine Bay-Jensen
Morten Karsdal
Per Qvist
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HUE058848T2 publication Critical patent/HUE058848T2/hu

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1825Fibroblast growth factor [FGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HUE18782012A 2017-09-29 2018-09-28 FGF-18 vegyületre vonatkozó válaszkészség elõrejelzésére szolgáló gyulladásos biomarkerek HUE058848T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17194169 2017-09-29
EP18169317 2018-04-25

Publications (1)

Publication Number Publication Date
HUE058848T2 true HUE058848T2 (hu) 2022-09-28

Family

ID=63722379

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18782012A HUE058848T2 (hu) 2017-09-29 2018-09-28 FGF-18 vegyületre vonatkozó válaszkészség elõrejelzésére szolgáló gyulladásos biomarkerek

Country Status (16)

Country Link
US (2) US11467169B2 (https=)
EP (1) EP3688468B1 (https=)
JP (1) JP7418324B2 (https=)
CN (1) CN111164429B (https=)
AU (1) AU2018343980B2 (https=)
CA (1) CA3075713A1 (https=)
DK (1) DK3688468T3 (https=)
ES (1) ES2918249T3 (https=)
HR (1) HRP20220737T1 (https=)
HU (1) HUE058848T2 (https=)
IL (1) IL273574B2 (https=)
LT (1) LT3688468T (https=)
PL (1) PL3688468T3 (https=)
RS (1) RS63292B1 (https=)
SI (1) SI3688468T1 (https=)
WO (1) WO2019063756A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016211950A1 (en) 2015-01-29 2017-07-13 Ares Trading S.A. Immunoassays for high positively charged proteins
IL273613B2 (en) 2017-09-29 2026-02-01 Merck Patent Gmbh Metabolic biomarkers for predicting response to FGF-18 compound
SI3688468T1 (sl) 2017-09-29 2022-08-31 Merck Patent Gmbh Vnetni biomarkerji za predvidevanje odzivov na spojino FGF-18
IL281333B2 (en) 2018-09-10 2025-11-01 Merck Patent Gmbh A method for reducing risk in a clinical trial

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2339002A1 (en) 1996-10-16 2011-06-29 ZymoGenetics, Inc. Fibroblast growth factor homologs
ES2493840T3 (es) 2002-10-07 2014-09-12 Zymogenetics, Inc. Procedimiento de administración de FGF-18
AU2003287697A1 (en) 2002-11-08 2004-06-03 Barnes-Jewish Hospital Uncoupled collagen synthesis and degradation assays
AU2005314438B2 (en) 2004-12-10 2012-03-29 Zymogenetics, Inc. FGF18 production in prokaryotic hosts
US8224579B2 (en) 2005-06-17 2012-07-17 The Brigham And Women's Hospital, Inc. Method of diagnosing osteoarthritis
HRP20120643T1 (hr) 2006-08-25 2012-08-31 Ares Trading S.A. Liječenje poremećaja hrskavice sa fgf-18
JP2009257842A (ja) 2008-04-14 2009-11-05 Ttc:Kk 変形性関節症の検査方法及び診断用キット
JP5762282B2 (ja) 2008-05-02 2015-08-12 インタールーキン ジェネティクス, インコーポレイテッド 変形性関節症に関連する状態に対する遺伝的素因の検出
US20090299769A1 (en) 2008-05-29 2009-12-03 Nordic Bioscience Imaging A/S Prognostic osteoarthritis biomarkers
US20120115137A1 (en) 2010-08-31 2012-05-10 Kornman Kenneth S Methods of Predicting Osteoarthritis
TWI527590B (zh) 2011-06-17 2016-04-01 艾瑞斯貿易公司 Fgf-18之凍乾調配物
AU2013301607B2 (en) 2012-08-06 2018-10-18 Merck Patent Gmbh Prognosis biomarkers in cartilage disorders
CN104736723B (zh) * 2012-08-06 2017-10-31 默克专利有限公司 用于预测对fgf‑18化合物的响应性的遗传标记
CA2931978A1 (en) * 2013-12-02 2015-06-11 Abbvie Inc. Compositions and methods for treating osteoarthritis
KR102622290B1 (ko) 2013-12-24 2024-01-05 아레스 트레이딩 에스.아. 크실로글루칸 겔 중의 fgf-18 제형물
ES2806026T3 (es) 2013-12-24 2021-02-16 Ares Trading Sa Formulación de FGF-18 en hidrogeles de alginato/colágeno
HUE040350T2 (hu) * 2014-02-20 2019-03-28 Merck Patent Gmbh FGF-18 vegyületadagoló étrend
MX2016010873A (es) 2014-02-20 2016-11-17 Merck Patent Gmbh Factor de crecimiento de fibroblastos 18 en los procedimientos para el trasplante de injertos y para ingenieria de tejidos.
JP6510547B2 (ja) 2014-02-20 2019-05-08 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung Fgf−18を含むインプラント
AU2016211950A1 (en) 2015-01-29 2017-07-13 Ares Trading S.A. Immunoassays for high positively charged proteins
MX380092B (es) 2015-11-06 2025-03-11 Samumed Llc Tratamiento de la osteoartritis.
US9983214B2 (en) 2016-04-15 2018-05-29 Esm Technologies, Llc Method for evaluating articular joint therapeutics
SI3688468T1 (sl) 2017-09-29 2022-08-31 Merck Patent Gmbh Vnetni biomarkerji za predvidevanje odzivov na spojino FGF-18
IL273613B2 (en) 2017-09-29 2026-02-01 Merck Patent Gmbh Metabolic biomarkers for predicting response to FGF-18 compound
IL281333B2 (en) 2018-09-10 2025-11-01 Merck Patent Gmbh A method for reducing risk in a clinical trial

Also Published As

Publication number Publication date
RS63292B1 (sr) 2022-06-30
HRP20220737T1 (hr) 2022-09-02
IL273574B1 (en) 2024-09-01
AU2018343980A1 (en) 2020-04-02
CN111164429B (zh) 2024-08-09
AU2018343980B2 (en) 2025-04-10
ES2918249T3 (es) 2022-07-14
EP3688468B1 (en) 2022-03-16
LT3688468T (lt) 2022-06-27
US12332250B2 (en) 2025-06-17
US20230258659A1 (en) 2023-08-17
PL3688468T3 (pl) 2022-07-18
US11467169B2 (en) 2022-10-11
IL273574B2 (en) 2025-01-01
SI3688468T1 (sl) 2022-08-31
WO2019063756A1 (en) 2019-04-04
IL273574A (en) 2020-05-31
CA3075713A1 (en) 2019-04-04
JP7418324B2 (ja) 2024-01-19
EP3688468A1 (en) 2020-08-05
CN111164429A (zh) 2020-05-15
DK3688468T3 (da) 2022-06-20
JP2020535423A (ja) 2020-12-03
US20210231680A1 (en) 2021-07-29

Similar Documents

Publication Publication Date Title
EP3676792A4 (en) DYNAMIC SCRIPTS FOR TELEAGENTS
EP3488345A4 (en) TECHNOLOGIES FOR SLED-TYPE ARCHITECTURE
EP3548802A4 (en) SENSOR MODULES FOR LUMINAIRES
EP4119042C0 (en) TRANSCUTANEOUS ANALYTE SENSOR SYSTEMS
EP3311158A4 (en) BIOMARKER COUPLE AND PREDICTION OF AN EARLY BIRTH
DK3060582T3 (da) Assays til bestemmelse af plasmakallikreinsystem-biomarkører
DK3481964T3 (da) Biomarkører for inflammatorisk tarmsygdom
EP3487868A4 (en) WASHING PAD FOR AFFINITY CHROMATOGRAPHY
EP3295474A4 (en) Stress control for heteroepitaxy
DK3638680T3 (da) Heteroaromatiske forbindelser som vanininhibitorer
FR3007070B1 (fr) Ensemble pour turbomachine
EP3551411A4 (en) MASTER MOLD FOR PATTERN TRANSFER
EP3646634C0 (en) DYNAMIC PREDICTIVE BUFFERING
IL273574A (en) Inflammatory biomarkers for predicting response to FGF-18 compound
EP3581548A4 (en) MIXING BY ADMIXTION OF HYDRAULIC COMPOSITION
PL3655420T3 (pl) Chromatografia
MA43957A (fr) Biomarqueurs de copanlisib
MA43958A (fr) Biomarqueurs copanlisib
IL249443B (en) Biomarkers for response to ezh2 inhibitors
IL273613A (en) Metabolic biomarkers for predicting response to FGF-18 compound
DK3513192T3 (da) Celledødsbiomarkør
EP3328301A4 (en) POSTOPERATIVE FORECAST
EP3857231C0 (en) QUANTIFICATION OF ANALYTES
HUE060884T2 (hu) Homogén immunesszé háttérjel kompenzációjára
HUE064630T2 (hu) Prognosztikai biomarkerek TTK-inhibitoros kemoterápiához